PeptideDB

PKUMDL-LC-101-D04 2143896-83-5

PKUMDL-LC-101-D04 2143896-83-5

CAS No.: 2143896-83-5

PKUMDL-LC-101-D04 (GPX4-Activator-1d4) is a potent allosteric activator (pEC50=4.7) of the ferroptosis regulator glutath
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

PKUMDL-LC-101-D04 (GPX4-Activator-1d4) is a potent allosteric activator (pEC50=4.7) of the ferroptosis regulator glutathione peroxidase 4 (GPX4). PKUMDL-LC-101-D04 increased GPX4 activity to 150% at 20 μM in cell-free assays and 61 μM in cell extracts.

Physicochemical Properties


Molecular Formula C14H23CLN4O2S2
Molecular Weight 378.941019296646
Exact Mass 378.095
Elemental Analysis C, 44.38; H, 6.12; Cl, 9.36; N, 14.79; O, 8.44; S, 16.92
CAS # 2143896-83-5
Related CAS # 2143896-83-5 (HCl);2143896-82-4;
PubChem CID 155543553
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 5
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 6
Heavy Atom Count 23
Complexity 450
Defined Atom Stereocenter Count 0
SMILES

Cl.S(C1C=CC(=CC=1)NC(NC1CCCC1)=S)(NCCN)(=O)=O

InChi Key FELDRJSFLBINQS-UHFFFAOYSA-N
InChi Code

InChI=1S/C14H22N4O2S2.ClH/c15-9-10-16-22(19,20)13-7-5-12(6-8-13)18-14(21)17-11-3-1-2-4-11;/h5-8,11,16H,1-4,9-10,15H2,(H2,17,18,21);1H
Chemical Name

N-(2-aminoethyl)-4-[[(cyclopentylamino)thioxomethyl]amino]-benzenesulfonamide, monohydrochloride
Synonyms

PKUMDL-LC-101-D04 ;
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4. J Med Chem. 2019;62(1):266-275.


Solubility Data


Solubility (In Vitro) DMSO : ~250 mg/mL (~659.74 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.08 mg/mL (5.49 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6389 mL 13.1947 mL 26.3894 mL
5 mM 0.5278 mL 2.6389 mL 5.2779 mL
10 mM 0.2639 mL 1.3195 mL 2.6389 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.